Vertex Pharmaceuticals Incorporated
Explore Vertex Pharmaceuticals
Core profile pages, annual revenue records, and related research hubs for this company.
Vertex Pharmaceuticals Incorporated
Explore Vertex Pharmaceuticals
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$12.0B
Market Cap
$123.5B
Employees
5,000
Vertex reported USD 12.0 billion in 2025 total revenue, up 9% from 2024. Product revenue was approximately USD 11.97 billion, and the company provided 2026 total revenue guidance of USD 12.95 billion to USD 13.1 billion. The financial profile is still powered by high-margin specialty medicines, but the mix is beginning to broaden as non-CF products launch. R&D investment remains central to the model because pipeline renewal is the answer to long-term patent and concentration risk.
Revenue Trend Analysis
YoY Change
+8.9%
2-Year CAGR
+10.3%
Peak Year
2025
Trend
Consistent Growth
Vertex Pharmaceuticals Incorporated has reported revenue across 3 fiscal years, compounding at +10.3% annually over 2 years. The most recent year saw a 8.9% increase versus the prior year. Revenue peaked in 2025 at $12.0B. Out of 2 reported periods, 2 showed growth and 0 showed a decline.
| Fiscal Year | Revenue | YoY Change |
|---|---|---|
| FY2025 | $12.0B | +8.9% |
| FY2024 | $11.0B | +11.7% |
| FY2023 | $9.9B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Vertex Pharmaceuticals Incorporated Revenue & Financials." CorpDigest, https://corpdigest.com/company/vertex/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Vertex Pharmaceuticals Incorporated reported $12B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/vertex/financials" target="_blank" rel="noopener">CorpDigest — Vertex Pharmaceuticals Incorporated financials</a></div>